|
39
|
114
|
5w0eA |
Crebbp bromodomain in complex with cpd19 (3-(7-(difluoromethyl)-6-(1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-n-methyl-1-(tetrahydro-2h-pyran-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridine-5-carboxamide) |
|
2
|
9
|
5x8uB |
Crystal structure of the wild human ror gamma ligand binding domain. |
|
2
|
11
|
5nmbB2 |
Structure-activity relationship study of vitamin d analogs with oxolane group in their side chain |
|
2
|
10
|
5mx7B1 |
1a,20s-dihydroxyvitamin d3 vdr complex |
|
38
|
108
|
5fe0A |
Crystal structure of human pcaf bromodomain in complex with acetyllysine |
|
26
|
116
|
5b77A |
Crystal structrue of moz double phd finger in complex with histone h3 propionylation at k14 |
|
29
|
119
|
5b78A |
Crystal structure of moz double phd finger mutant-s210d/n235r in complex with histone h3 crotonylation at k14 |
|
43
|
114
|
5bt3A |
Crystal structure of ep300 bromodomain in complex with sgc-cbp30 chemical probe |
|
26
|
120
|
5b76A |
Crystal structure of moz double phd finger domain in complex with histone h3 crotonylation at k14 |
|
25
|
119
|
5b75A |
Crystal structure of moz double phd finger in complex with histone h3 butyrylation at k14 |
|
4
|
15
|
5a86C |
Structure of pregnane x receptor in complex with a sphingosine 1- phosphate receptor 1 antagonist |
|
50
|
132
|
4yymA |
Crystal structure of taf1 bd2 bromodomain bound to a butyryllysine peptide |
|
54
|
130
|
4yynA |
Crystal structure of taf1 bd2 bromodomain bound to a crotonyllysine peptide |
|
3
|
11
|
4f9mC |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
94
|
343
|
4f3lA |
Crystal structure of the heterodimeric clock:bmal1 transcriptional activator complex |
|
4
|
10
|
4dqmB |
Revealing a marine natural product as a novel agonist for retinoic acid receptors with a unique binding mode and antitumor activity |
|
3
|
12
|
4dk7B |
Crystal structure of lxr ligand binding domain in complex with full agonist 1 |
|
1
|
8
|
4dm8C |
Crystal structure of rarb lbd in complex with 9cis retinoic acid |
|
72
|
272
|
4dncA |
Crystal structure of human mof in complex with msl1 |
|
2
|
11
|
4dmaE |
Crystal structure of era lbd in complex with ru100132 |
|
2
|
12
|
4dk8B |
Crystal structure of lxr ligand binding domain in complex with partial agonist 5 |
|
3
|
11
|
4dm6E |
Crystal structure of rarb lbd homodimer in complex with ttnpb |
|
97
|
264
|
4ci4A |
Structural basis for gl479 a dual peroxisome proliferator-activated receptor alpha agonist |
|
100
|
263
|
4bcrA |
Structure of pparalpha in complex with wy14643 |
|
58
|
256
|
4b0aA |
The high-resolution structure of ytbp-ytaf1 identifies conserved and competing interaction surfaces in transcriptional activation |
|
161
|
563
|
4bhwA |
Structural basis for autoinhibition of the acetyltransferase activity of p300 |
|
39
|
115
|
4a9kA |
Bromodomain of human crebbp with n-(4-hydroxyphenyl)acetamide |
|
84
|
310
|
5iybM |
Human core-pic in the open state |
|
72
|
310
|
5iy6M |
Human holo-pic in the closed state |
|
2
|
11
|
3vn2C |
Crystal structure of ppargamma complexed with telmisartan |
|
22
|
112
|
3v43A |
Crystal structure of moz |
|
3
|
11
|
3v9yB |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
2
|
9
|
3uu7F |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-a |
|
2
|
9
|
3uudC |
Crystal structure of hera-lbd (y537s) in complex with estradiol |
|
48
|
125
|
3uv4A |
Crystal structure of the second bromodomain of human transcription initiation factor tfiid subunit 1 (taf1) |
|
100
|
255
|
3uv5A |
Crystal structure of the tandem bromodomains of human transcription initiation factor tfiid subunit 1 (taf1) |
|
2
|
9
|
3uuaF |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-af |
|
80
|
276
|
3to6A |
Crystal structure of yeast esa1 hat domain complexed with h4k16coa bisubstrate inhibitor |
|
79
|
276
|
3to7A |
Crystal structure of yeast esa1 hat domain bound to coenzyme a with active site lysine acetylated |
|
83
|
276
|
3to9A |
Crystal structure of yeast esa1 e338q hat domain bound to coenzyme a with active site lysine acetylated |
|
73
|
271
|
3toaA |
Human mof crystal structure with active site lysine partially acetylated |
|
79
|
271
|
3tobA |
Human mof e350q crystal structure with active site lysine partially acetylated |
|
44
|
113
|
3t92A |
Crystal structure of the taz2:c/ebpepsilon-tad chimera protein |
|
2
|
8
|
3t03C |
Crystal structure of ppar gamma ligand binding domain in complex with a novel partial agonist gq-16 |
|
2
|
11
|
3rutB |
Fxr with src1 and gsk359 |
|
2
|
11
|
3ruuB |
Fxr with src1 and gsk237 |
|
3
|
11
|
3rvfB |
Fxr with src1 and gsk2034 |
|
92
|
290
|
3r8dA |
Activation of the human nuclear xenobiotic receptor pxr by the reverse transcriptase-targeted anti-hiv drug pnu-142721 |
|
3
|
11
|
5ycnB |
Human ppargamma ligand binding domain complexed with lobeglitazone |
|
4
|
15
|
5x0rC |
Crystal structure of pxr lbd complexed with sjb7 |
